Showing results (2431-2440 of 5,699) with videos related to

Sort By:
Pageof 570
BMC Neurology|July 21, 2012
The effect of stimulation therapy and donepezil on cognitive function in Alzheimer's disease. A community based RCT with a two-by-two factorial designFred Andersen, Matti Viitanen, Dag S Halvorsen, et al.
BMC Neurology|July 18, 2012
Brief International Cognitive Assessment for MS (BICAMS): international standards for validationRalph H B Benedict, Maria Pia Amato, Jan Boringa, et al.
BMC Neurology|June 30, 2012
Huntington's disease and its therapeutic target genes: a global functional profile based on the HD Research Crossroads databaseRavi Kiran Reddy Kalathur, Miguel A Hernández-Prieto, Matthias E Futschik
BMC Neurology|February 5, 2015
Defining pediatric traumatic brain injury using International Classification of Diseases Version 10 Codes: a systematic reviewVincy Chan, Pravheen Thurairajah, Angela Colantonio
BMC Neurology|July 27, 2022
Burden of stroke in North Africa and Middle East, 1990 to 2019: a systematic analysis for the global burden of disease study 2019Ataollah Shahbandi, Parnian Shobeiri, Sina Azadnajafabad, et al.
BMC Neurology|July 19, 2022
SLC20A2-related primary familial brain calcification with purely acute psychiatric symptoms: a case reportWeiting Bu, Lijing Hou, Meijia Zhu, et al.
BMC Neurology|April 12, 2022
Godtfredsen syndrome - recurrent clival chondrosarcoma with 6 years follow up: a case report and literature reviewYong Zheng Wai, Yong Yuin Chong, Noraini Mohd Dusa, et al.
BMC Neurology|April 12, 2022
Epilepsy in patients undergoing cardiac surgery with ExtraCorporeal Circulation: case series and description of a peculiar clinical phenotypeMatteo Pugnaghi, Francesco Cavallieri, Mauro Zennaro, et al.
BMC Neurology|April 13, 2022
Covid-19 threat and coping: application of protection motivation theory to the pandemic experiences of people affected by amyotrophic lateral sclerosisShelagh K Genuis, Westerly Luth, Tania Bubela, et al.
BMC Neurology|April 16, 2022
Real-world effectiveness and safety of fingolimod in patients with multiple sclerosis in the Czech Republic: results from core and extension parts of the GOLEMS study up to 48 monthsVeronika Tichá, Zuzana Počíková, Josef Vytlačil, et al.
Pageof 570